Clinical trial
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women…
NCT00092521 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092521 |
|---|---|
| Title | Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) |
| Official title | A Study to Evaluate the Efficacy of Quadrivalent HPV Vaccine in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related CIN, AIS, and Cervical Cancer, and HPV 6-, 11-, 16-, and 18-Related External Genital Warts, Vulvar Intraepithelial Neoplasia Vaginal Intraepithelial Neoplasia, Vulvar Cancer… |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Genital Warts |
| Intervention type | Biological |
| Interventions | V501, Comparator: Placebo, Human Papillomavirus (HPV) 16 Monovalent |
| Enrollment | 5,759 |
| Start date | Dec 1, 2001 |
| Primary completion | Jul 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Sep 28, 2004 |
| Last update posted | Sep 25, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: